Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ivor Douglas

Concepts (598)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial
24
2025
613
3.850
 Why?
Sepsis
20
2025
572
2.880
 Why?
Fluid Therapy
12
2025
133
2.500
 Why?
Respiratory Insufficiency
12
2023
312
2.350
 Why?
Critical Care
19
2025
551
2.280
 Why?
Critical Illness
20
2025
757
2.130
 Why?
Intensive Care Units
24
2025
735
2.090
 Why?
Tracheostomy
5
2024
121
1.770
 Why?
Shock, Septic
11
2024
209
1.590
 Why?
Hospital Mortality
19
2024
846
1.540
 Why?
Shock
3
2024
92
1.460
 Why?
Hospitals
6
2023
630
1.310
 Why?
Hypotension
5
2025
116
1.250
 Why?
Pneumonia
7
2023
616
1.160
 Why?
Resuscitation Orders
3
2023
43
1.020
 Why?
Resuscitation
9
2025
236
0.980
 Why?
Multiple Organ Failure
4
2024
122
0.980
 Why?
Patient Readmission
6
2021
652
0.880
 Why?
Humans
135
2025
129144
0.880
 Why?
Vasoconstrictor Agents
5
2023
127
0.860
 Why?
Ultrasonography, Doppler
1
2024
118
0.840
 Why?
Middle Aged
58
2025
31050
0.830
 Why?
Aged
45
2025
21997
0.810
 Why?
Pneumonia, Ventilator-Associated
2
2015
49
0.810
 Why?
Safety-net Providers
3
2023
109
0.760
 Why?
Hospitals, High-Volume
2
2019
39
0.750
 Why?
Hemodynamics
3
2024
1090
0.740
 Why?
Severity of Illness Index
6
2021
2736
0.720
 Why?
Monitoring, Physiologic
4
2024
265
0.720
 Why?
Extracorporeal Membrane Oxygenation
2
2023
282
0.710
 Why?
Retrospective Studies
31
2025
14450
0.700
 Why?
Patient Acceptance of Health Care
5
2021
757
0.700
 Why?
Patient Positioning
1
2021
52
0.690
 Why?
Frailty
1
2023
152
0.690
 Why?
Male
73
2025
63456
0.690
 Why?
Diabetes Insipidus
1
2020
7
0.680
 Why?
Practice Guidelines as Topic
6
2021
1496
0.660
 Why?
Substance Withdrawal Syndrome
3
2021
176
0.630
 Why?
Hospitals, Low-Volume
1
2019
22
0.620
 Why?
Noninvasive Ventilation
4
2025
49
0.600
 Why?
Dyspnea
2
2021
238
0.590
 Why?
Female
64
2025
68494
0.580
 Why?
Adult
44
2025
35469
0.570
 Why?
Delirium
3
2025
78
0.560
 Why?
Pulmonary Disease, Chronic Obstructive
8
2025
983
0.550
 Why?
Diabetes Mellitus
2
2020
1000
0.550
 Why?
Alcoholism
5
2021
765
0.530
 Why?
Ventilator-Induced Lung Injury
3
2018
58
0.530
 Why?
Pulmonary Medicine
3
2015
79
0.520
 Why?
California
5
2022
400
0.520
 Why?
Microbiological Techniques
1
2016
30
0.510
 Why?
Sleep Medicine Specialty
1
2015
9
0.500
 Why?
Acute Lung Injury
6
2023
279
0.490
 Why?
Neoplasms
3
2023
2442
0.490
 Why?
Molecular Diagnostic Techniques
1
2016
98
0.470
 Why?
Health Policy
4
2024
351
0.470
 Why?
Hyperemia
3
2024
48
0.470
 Why?
Ethanol
2
2021
589
0.460
 Why?
Randomized Controlled Trials as Topic
10
2023
1363
0.460
 Why?
Acute Kidney Injury
7
2023
789
0.450
 Why?
Research Design
9
2023
1042
0.450
 Why?
Aged, 80 and over
13
2025
7037
0.440
 Why?
Cohort Studies
11
2023
5408
0.430
 Why?
Renin-Angiotensin System
2
2025
82
0.420
 Why?
Prone Position
3
2021
30
0.420
 Why?
Receptor, EphA2
3
2018
19
0.420
 Why?
Bronchoalveolar Lavage Fluid
2
2016
644
0.410
 Why?
Cause of Death
3
2015
392
0.410
 Why?
Inpatients
3
2023
461
0.410
 Why?
Laryngoscopes
2
2023
34
0.400
 Why?
Immune Tolerance
1
2015
355
0.400
 Why?
Nicotinic Agonists
1
2014
120
0.400
 Why?
Dual Specificity Phosphatase 1
1
2012
26
0.390
 Why?
Cross Infection
5
2020
217
0.390
 Why?
Marijuana Smoking
1
2015
247
0.390
 Why?
Hospitalization
10
2025
2052
0.380
 Why?
Apoptosis
6
2014
2491
0.370
 Why?
Lung
12
2018
3927
0.370
 Why?
Tobacco Use Disorder
1
2014
236
0.370
 Why?
Nicotine
1
2014
302
0.360
 Why?
Lipopolysaccharides
4
2017
877
0.360
 Why?
Organ Dysfunction Scores
2
2024
44
0.360
 Why?
Tissue Plasminogen Activator
2
2024
222
0.360
 Why?
Pulmonary Fibrosis
4
2017
384
0.360
 Why?
Immunity, Innate
1
2017
803
0.360
 Why?
Drug Delivery Systems
1
2014
332
0.350
 Why?
Protein C
5
2012
47
0.350
 Why?
Glycosaminoglycans
3
2016
84
0.350
 Why?
Prospective Studies
12
2024
7117
0.350
 Why?
Child Development
1
2015
457
0.340
 Why?
Long-Term Care
2
2022
92
0.340
 Why?
Emergency Service, Hospital
5
2024
1896
0.330
 Why?
Smoking Cessation
1
2014
405
0.330
 Why?
Antipsychotic Agents
2
2024
195
0.320
 Why?
Vena Cava, Inferior
3
2024
68
0.320
 Why?
Comorbidity
4
2022
1544
0.310
 Why?
Metabolic Syndrome
2
2023
339
0.310
 Why?
Public Health
1
2014
483
0.310
 Why?
Length of Stay
6
2024
1120
0.310
 Why?
United States
18
2024
13825
0.310
 Why?
Ephrin-A1
3
2018
4
0.310
 Why?
Treatment Outcome
15
2024
10192
0.310
 Why?
Cannabis
1
2015
462
0.300
 Why?
Lipid A
2
2014
29
0.300
 Why?
Institutional Practice
1
2008
3
0.300
 Why?
Intubation, Intratracheal
4
2024
239
0.300
 Why?
Societies, Medical
7
2021
744
0.290
 Why?
Betacoronavirus
2
2020
248
0.290
 Why?
Odds Ratio
6
2019
1017
0.290
 Why?
Biomarkers
7
2023
3963
0.280
 Why?
Personnel Staffing and Scheduling
1
2008
89
0.280
 Why?
Pandemics
4
2024
1482
0.280
 Why?
Neutrophils
3
2024
1207
0.280
 Why?
Anti-Bacterial Agents
1
2017
1702
0.270
 Why?
Pulmonary Alveolar Proteinosis
1
2007
17
0.270
 Why?
Integrins
1
2007
94
0.270
 Why?
Neovascularization, Pathologic
2
2007
295
0.270
 Why?
Haloperidol
3
2025
32
0.270
 Why?
MAP Kinase Signaling System
2
2014
312
0.260
 Why?
Patient Admission
2
2023
181
0.260
 Why?
Hyponatremia
1
2006
39
0.260
 Why?
Lung Injury
3
2016
210
0.260
 Why?
Lung Diseases, Obstructive
1
2006
46
0.250
 Why?
Renal Insufficiency, Chronic
2
2024
566
0.250
 Why?
Ultrasonography
3
2024
712
0.250
 Why?
Leukocytes
1
2007
306
0.250
 Why?
Double-Blind Method
9
2024
1874
0.250
 Why?
Pneumonia, Viral
2
2020
339
0.250
 Why?
Coronavirus Infections
2
2020
333
0.250
 Why?
Medicaid
3
2021
431
0.240
 Why?
Laryngoscopy
2
2023
97
0.240
 Why?
Biomedical Research
3
2021
637
0.240
 Why?
Academic Medical Centers
3
2021
474
0.240
 Why?
Chemokines, CXC
1
2005
70
0.240
 Why?
Bronchi
1
2006
247
0.240
 Why?
Regeneration
1
2006
181
0.230
 Why?
Oxazines
1
2024
27
0.230
 Why?
Bronchiectasis
1
2006
109
0.230
 Why?
Bronchiolitis Obliterans
1
2005
68
0.230
 Why?
Adrenal Insufficiency
2
2013
32
0.230
 Why?
Infusions, Intravenous
5
2024
399
0.230
 Why?
Methylprednisolone
1
2005
83
0.230
 Why?
Phagocytosis
1
2006
362
0.230
 Why?
Venous Pressure
1
2024
8
0.230
 Why?
Patient Protection and Affordable Care Act
2
2016
98
0.220
 Why?
Plasminogen
1
2024
31
0.220
 Why?
Morpholines
1
2024
122
0.220
 Why?
Leukocyte Elastase
1
2024
74
0.220
 Why?
Respiratory Mucosa
1
2006
308
0.220
 Why?
Vasopressins
3
2021
64
0.220
 Why?
Plasminogen Activator Inhibitor 1
1
2024
84
0.220
 Why?
Anti-Infective Agents
4
2012
247
0.220
 Why?
Cytokines
7
2017
2012
0.220
 Why?
beta Catenin
1
2005
225
0.210
 Why?
Atrial Pressure
1
2023
3
0.210
 Why?
Renal Dialysis
4
2023
423
0.210
 Why?
Hypoxia
3
2024
1084
0.210
 Why?
Receptor, Angiotensin, Type 1
1
2023
22
0.210
 Why?
Risk Factors
10
2021
9740
0.210
 Why?
Diterpenes
2
2014
32
0.210
 Why?
Area Under Curve
3
2020
304
0.210
 Why?
Craniocerebral Trauma
1
2005
151
0.200
 Why?
Analgesics, Non-Narcotic
1
2024
119
0.200
 Why?
Lung Diseases
3
2016
739
0.200
 Why?
Hemodynamic Monitoring
1
2022
1
0.200
 Why?
Fibrinolysis
1
2024
137
0.200
 Why?
Thiazoles
2
2024
117
0.200
 Why?
Fibrosis
1
2005
520
0.200
 Why?
Treatment Failure
6
2021
338
0.200
 Why?
Evidence-Based Medicine
5
2016
712
0.190
 Why?
Acetaminophen
1
2024
246
0.190
 Why?
Early Diagnosis
4
2017
233
0.190
 Why?
Transportation
1
2022
50
0.190
 Why?
Clinical Decision-Making
1
2024
301
0.190
 Why?
Logistic Models
7
2017
1982
0.180
 Why?
Vasodilator Agents
1
2023
326
0.180
 Why?
Hydrocortisone
1
2003
306
0.180
 Why?
Central Nervous System Depressants
1
2021
82
0.180
 Why?
Pyridines
1
2024
478
0.180
 Why?
Receptors, Interleukin-6
1
2021
37
0.180
 Why?
Heart Arrest
2
2021
320
0.180
 Why?
Stroke Volume
1
2024
592
0.170
 Why?
Hospital Charges
1
2020
41
0.170
 Why?
Piperazines
2
2024
340
0.170
 Why?
Health Priorities
1
2020
34
0.170
 Why?
Rib Fractures
1
2020
32
0.170
 Why?
Hydroxychloroquine
1
2020
55
0.170
 Why?
Glucocorticoids
1
2005
578
0.170
 Why?
Community-Acquired Infections
3
2020
160
0.170
 Why?
Internship and Residency
2
2019
1046
0.170
 Why?
Reproducibility of Results
5
2024
3077
0.170
 Why?
Antigens, Differentiation
1
2000
81
0.170
 Why?
Heart Failure
3
2023
2129
0.160
 Why?
Animals
20
2018
35286
0.160
 Why?
Patient Selection
1
2023
660
0.160
 Why?
Cell Proliferation
2
2014
2368
0.160
 Why?
Patient Handoff
1
2019
30
0.160
 Why?
Risk Adjustment
1
2020
79
0.160
 Why?
Cell Adhesion Molecules
1
2000
173
0.150
 Why?
Hospital Costs
1
2019
114
0.150
 Why?
Dopamine Antagonists
1
2018
23
0.150
 Why?
Mice, Inbred C57BL
9
2018
5438
0.150
 Why?
Age Factors
4
2019
3140
0.150
 Why?
Combined Modality Therapy
2
2020
1198
0.150
 Why?
ROC Curve
1
2020
502
0.150
 Why?
Blood Glucose Self-Monitoring
1
2023
601
0.150
 Why?
Antimicrobial Stewardship
1
2020
104
0.150
 Why?
Orthopedic Procedures
1
2020
208
0.150
 Why?
Thrombosis
1
2021
343
0.140
 Why?
Caregivers
1
2025
802
0.140
 Why?
Health Services Accessibility
4
2020
899
0.140
 Why?
Optometry
1
2017
6
0.140
 Why?
Eosinophils
1
2000
324
0.140
 Why?
Guideline Adherence
2
2014
525
0.140
 Why?
Platelet Count
2
2014
82
0.140
 Why?
Cell Adhesion
4
2012
452
0.140
 Why?
Tidal Volume
2
2014
84
0.140
 Why?
Predictive Value of Tests
4
2016
1943
0.140
 Why?
Blood Glucose
2
2023
2098
0.140
 Why?
Lymphocyte Count
1
2017
148
0.130
 Why?
Analysis of Variance
1
2020
1288
0.130
 Why?
Transients and Migrants
1
2017
25
0.130
 Why?
Pyrimidines
2
2024
458
0.130
 Why?
Mice
13
2017
16905
0.130
 Why?
Cystic Fibrosis
1
2006
1053
0.130
 Why?
Tretinoin
1
2017
130
0.130
 Why?
Nephrectomy
2
2008
158
0.130
 Why?
Health Insurance Exchanges
1
2016
1
0.130
 Why?
Delivery of Health Care
1
2023
892
0.130
 Why?
Continuity of Patient Care
1
2018
272
0.130
 Why?
Risk Management
1
2017
85
0.130
 Why?
Clinical Trials as Topic
1
2021
1003
0.130
 Why?
Attitude of Health Personnel
3
2019
1094
0.130
 Why?
Ventricular Function, Right
1
2018
276
0.130
 Why?
Sleep Wake Disorders
2
2017
251
0.130
 Why?
Breath Tests
1
2016
87
0.120
 Why?
Antibodies, Monoclonal, Humanized
1
2021
757
0.120
 Why?
Ventricular Dysfunction, Right
1
2018
231
0.120
 Why?
Burnout, Professional
1
2021
404
0.120
 Why?
Respiratory Tract Diseases
1
2017
148
0.120
 Why?
Research
1
2018
416
0.120
 Why?
Survival Analysis
4
2014
1268
0.120
 Why?
Alcohol Withdrawal Seizures
1
2014
1
0.120
 Why?
Staphylococcus aureus
2
2011
434
0.120
 Why?
Alcohol Withdrawal Delirium
1
2014
7
0.120
 Why?
Marriage
1
2016
113
0.120
 Why?
Automation
1
2015
81
0.120
 Why?
Bronchoalveolar Lavage
1
2015
92
0.120
 Why?
5-Lipoxygenase-Activating Protein Inhibitors
1
2014
1
0.120
 Why?
5-Lipoxygenase-Activating Proteins
1
2014
4
0.120
 Why?
Bacteriological Techniques
1
2015
69
0.110
 Why?
Prognosis
5
2021
3766
0.110
 Why?
Risk Assessment
5
2015
3231
0.110
 Why?
Multicenter Studies as Topic
3
2023
285
0.110
 Why?
Patient Care Team
1
2019
600
0.110
 Why?
Fluorobenzenes
1
2014
15
0.110
 Why?
Leukotrienes
1
2014
37
0.110
 Why?
Phenanthrenes
1
2014
12
0.110
 Why?
Physicians
2
2021
859
0.110
 Why?
Quality of Life
2
2024
2680
0.110
 Why?
APACHE
2
2011
65
0.110
 Why?
Education, Medical
1
2017
244
0.110
 Why?
Down-Regulation
2
2017
636
0.110
 Why?
Catheterization, Central Venous
1
2015
103
0.110
 Why?
Potassium
1
2014
143
0.110
 Why?
Alanine Transaminase
1
2014
153
0.110
 Why?
Poverty
2
2016
496
0.110
 Why?
Systemic Inflammatory Response Syndrome
1
2014
85
0.110
 Why?
Kaplan-Meier Estimate
5
2018
851
0.110
 Why?
CD4-Positive T-Lymphocytes
1
2000
1056
0.110
 Why?
Laryngeal Masks
1
2013
10
0.110
 Why?
Microscopy
1
2015
141
0.110
 Why?
Quinolines
1
2014
156
0.100
 Why?
Time Factors
7
2023
6541
0.100
 Why?
Health Knowledge, Attitudes, Practice
2
2024
1276
0.100
 Why?
Glycocalyx
1
2012
21
0.100
 Why?
Patient Discharge
1
2018
835
0.100
 Why?
Sensitivity and Specificity
2
2015
1833
0.100
 Why?
Patient-Centered Care
1
2017
505
0.100
 Why?
Physician-Patient Relations
1
2017
538
0.100
 Why?
Supine Position
1
2012
38
0.100
 Why?
Acute Disease
3
2016
978
0.100
 Why?
Cisplatin
1
2014
299
0.100
 Why?
Biomarkers, Pharmacological
1
2012
26
0.100
 Why?
Data Interpretation, Statistical
2
2011
336
0.100
 Why?
Oxygen
3
2023
914
0.100
 Why?
I-kappa B Proteins
1
2012
79
0.090
 Why?
Clinical Alarms
1
2011
10
0.090
 Why?
Insurance, Health
1
2014
265
0.090
 Why?
Data Display
1
2011
20
0.090
 Why?
Health Status
1
2017
754
0.090
 Why?
Follow-Up Studies
5
2024
4882
0.090
 Why?
Endotoxemia
1
2012
86
0.090
 Why?
Adrenergic beta-2 Receptor Agonists
1
2011
35
0.090
 Why?
Indoles
1
2014
383
0.090
 Why?
Albuterol
1
2011
102
0.090
 Why?
Genetic Markers
1
2012
336
0.090
 Why?
Sulfonamides
1
2014
495
0.090
 Why?
Fibrinolytic Agents
2
2024
262
0.080
 Why?
Alcohol-Related Disorders
1
2011
118
0.080
 Why?
Peroxidase
2
2008
174
0.080
 Why?
Stenotrophomonas maltophilia
1
2009
2
0.080
 Why?
Recombinant Proteins
5
2012
1304
0.080
 Why?
Decision Making
1
2017
848
0.080
 Why?
Thoracic Diseases
1
2009
14
0.080
 Why?
Clinical Protocols
2
2012
254
0.080
 Why?
Interferons
1
2011
191
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
430
0.080
 Why?
Survival Rate
3
2015
1869
0.080
 Why?
Wounds and Injuries
1
2016
710
0.080
 Why?
Adrenal Cortex Hormones
1
2013
522
0.080
 Why?
Ligands
2
2023
620
0.080
 Why?
Symptom Assessment
2
2020
125
0.080
 Why?
Gram-Negative Bacterial Infections
1
2009
45
0.080
 Why?
Blotting, Western
1
2012
1202
0.080
 Why?
Cell Movement
3
2011
944
0.080
 Why?
Databases, Factual
2
2016
1266
0.080
 Why?
Disease Models, Animal
5
2018
4056
0.080
 Why?
Polymerase Chain Reaction
1
2012
1033
0.080
 Why?
Confidence Intervals
1
2010
316
0.080
 Why?
Up-Regulation
1
2012
838
0.080
 Why?
Cues
1
2011
325
0.080
 Why?
Age Distribution
1
2010
372
0.080
 Why?
Sex Distribution
1
2010
359
0.080
 Why?
Pancreatitis
1
2009
129
0.080
 Why?
Pneumonia, Bacterial
1
2009
115
0.070
 Why?
Pulmonary Alveoli
2
2012
400
0.070
 Why?
Work Schedule Tolerance
1
2008
42
0.070
 Why?
Models, Statistical
1
2012
623
0.070
 Why?
Clinical Trials, Phase III as Topic
2
2023
93
0.070
 Why?
Healthcare Disparities
1
2014
574
0.070
 Why?
Incidence
1
2014
2635
0.070
 Why?
United Kingdom
1
2008
257
0.070
 Why?
Interleukin-6
2
2008
720
0.070
 Why?
Flavonoids
1
2007
77
0.070
 Why?
Pulmonary Emphysema
2
2007
275
0.070
 Why?
Mandatory Programs
1
2007
15
0.070
 Why?
Child, Preschool
2
2015
10456
0.070
 Why?
Clinical Competence
1
2014
1013
0.070
 Why?
Demeclocycline
1
2006
3
0.070
 Why?
Disease Progression
4
2017
2622
0.070
 Why?
Mice, Inbred C3H
1
2007
272
0.070
 Why?
Lithium Compounds
1
2006
11
0.070
 Why?
Methicillin Resistance
1
2006
18
0.070
 Why?
Workload
1
2008
153
0.070
 Why?
Signal Transduction
4
2018
4919
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
151
0.070
 Why?
Rats, Sprague-Dawley
1
2012
2395
0.070
 Why?
Carcinoma, Non-Small-Cell Lung
1
1995
1049
0.070
 Why?
Mitogen-Activated Protein Kinase 1
1
2007
184
0.060
 Why?
Intercellular Adhesion Molecule-1
2
2012
135
0.060
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2006
100
0.060
 Why?
Diuretics
1
2006
75
0.060
 Why?
Hospitals, Urban
2
2018
129
0.060
 Why?
Hospital Information Systems
1
2006
14
0.060
 Why?
Mesoderm
1
2007
137
0.060
 Why?
Sex Factors
3
2018
1964
0.060
 Why?
History, 20th Century
2
2017
291
0.060
 Why?
Adolescent
5
2025
20297
0.060
 Why?
Radiography, Thoracic
1
2007
166
0.060
 Why?
Asparagine
1
2005
30
0.060
 Why?
Butylated Hydroxytoluene
1
2005
38
0.060
 Why?
Mice, Inbred BALB C
2
2005
1246
0.060
 Why?
Protein Kinase Inhibitors
2
2024
885
0.060
 Why?
Rats
2
2012
5479
0.060
 Why?
Vocabulary
1
2006
46
0.060
 Why?
Cyclin D1
1
2005
63
0.060
 Why?
Emphysema
1
2006
109
0.060
 Why?
Bronchoscopy
1
2007
215
0.060
 Why?
Heparin
1
2007
253
0.060
 Why?
Cell Line, Transformed
1
2005
141
0.060
 Why?
Young Adult
5
2025
12385
0.060
 Why?
Medical Order Entry Systems
1
2006
43
0.060
 Why?
Occupational Health
1
2008
192
0.060
 Why?
Caspase Inhibitors
1
2005
83
0.060
 Why?
Blood Vessels
1
2007
187
0.060
 Why?
Hypertension, Pulmonary
2
2007
1894
0.060
 Why?
Gene Expression Regulation
2
2012
2536
0.060
 Why?
Angiotensin I
1
2025
7
0.060
 Why?
Venous Thrombosis
1
2007
175
0.060
 Why?
Gene Expression Profiling
1
2012
1683
0.060
 Why?
Ischemia
1
2008
405
0.060
 Why?
Neuromuscular Nondepolarizing Agents
1
2024
13
0.060
 Why?
Necrosis
1
2005
231
0.060
 Why?
Androstanols
1
2024
16
0.060
 Why?
HMGB1 Protein
1
2005
48
0.060
 Why?
Caspases
1
2005
245
0.060
 Why?
Hope
1
2024
22
0.060
 Why?
Pyridazines
1
2024
54
0.060
 Why?
Macrophages
2
2014
1481
0.060
 Why?
Colorado
4
2017
4402
0.060
 Why?
Cadherins
1
2005
187
0.060
 Why?
Medicago
1
2023
1
0.060
 Why?
Diabetic Ketoacidosis
1
2007
197
0.060
 Why?
T-Lymphocyte Subsets
1
2006
412
0.060
 Why?
Renal Replacement Therapy
1
2024
87
0.050
 Why?
Steroids
2
2021
158
0.050
 Why?
Uncertainty
1
2024
115
0.050
 Why?
Practice Patterns, Physicians'
3
2024
1266
0.050
 Why?
Enzyme Inhibitors
1
2007
827
0.050
 Why?
Atrial Function, Right
1
2023
12
0.050
 Why?
Angiotensins
1
2023
9
0.050
 Why?
Collagen
1
2005
433
0.050
 Why?
Multivariate Analysis
2
2017
1495
0.050
 Why?
Heparitin Sulfate
2
2014
42
0.050
 Why?
Mental Health
2
2022
684
0.050
 Why?
Biopsy
1
2007
1084
0.050
 Why?
Drug Administration Schedule
2
2018
767
0.050
 Why?
Inflammatory Bowel Diseases
1
2007
320
0.050
 Why?
Antineoplastic Agents
1
2014
2045
0.050
 Why?
Homeostasis
1
2006
605
0.050
 Why?
Autoimmune Diseases
1
2006
426
0.050
 Why?
Decision Support Techniques
2
2020
395
0.050
 Why?
Angiotensin II
1
2023
95
0.050
 Why?
Anticoagulants
1
2007
636
0.050
 Why?
Diagnosis, Differential
1
2007
1429
0.050
 Why?
Video Recording
1
2023
163
0.050
 Why?
Lung Neoplasms
1
1995
2340
0.050
 Why?
Hemoglobins
1
2024
339
0.050
 Why?
Child
2
2015
20768
0.050
 Why?
Staphylococcal Infections
1
2006
389
0.050
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
275
0.050
 Why?
Partial Thromboplastin Time
1
2021
52
0.050
 Why?
Creatinine
2
2015
490
0.050
 Why?
Endothelial Cells
1
2007
746
0.050
 Why?
Infant
1
2015
8975
0.050
 Why?
Oligopeptides
1
2023
258
0.050
 Why?
Perioperative Care
1
2022
151
0.040
 Why?
Electrocardiography
1
2024
608
0.040
 Why?
Antibodies
2
2018
398
0.040
 Why?
Peptide Fragments
1
2025
692
0.040
 Why?
Lung Diseases, Interstitial
1
2007
610
0.040
 Why?
Leukotriene C4
1
2000
11
0.040
 Why?
Hemorrhage
1
2005
678
0.040
 Why?
CD18 Antigens
1
2000
26
0.040
 Why?
N-Formylmethionine Leucyl-Phenylalanine
1
2000
55
0.040
 Why?
Chronic Disease
1
2006
1714
0.040
 Why?
Drug Resistance, Microbial
1
2020
69
0.040
 Why?
CD11 Antigens
1
2000
30
0.040
 Why?
Glasgow Coma Scale
1
2020
165
0.040
 Why?
Costs and Cost Analysis
1
2020
201
0.040
 Why?
Epithelial Cells
1
2005
1064
0.040
 Why?
Hospitals, University
1
2019
178
0.040
 Why?
Needs Assessment
1
2021
357
0.040
 Why?
Flow Cytometry
2
2017
1155
0.040
 Why?
Aftercare
1
2001
203
0.040
 Why?
Smoking
1
2006
1499
0.040
 Why?
Oxidative Stress
1
2005
1265
0.040
 Why?
NF-kappa B
2
2018
663
0.040
 Why?
Surveys and Questionnaires
3
2021
5382
0.040
 Why?
Algorithms
1
2006
1613
0.040
 Why?
Infection Control
1
2020
140
0.040
 Why?
Adjuvants, Immunologic
1
2000
221
0.040
 Why?
Injury Severity Score
1
2020
509
0.040
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2018
4
0.040
 Why?
Linear Models
1
2020
819
0.040
 Why?
Mice, Knockout
3
2012
2871
0.040
 Why?
T-Lymphocytes
1
2006
1932
0.040
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2018
37
0.040
 Why?
Trauma Centers
1
2020
402
0.040
 Why?
Victoria
1
2017
16
0.040
 Why?
Mortality
1
2019
307
0.030
 Why?
Family
1
2022
644
0.030
 Why?
History, 17th Century
1
2017
14
0.030
 Why?
Antigens, CD
1
2000
487
0.030
 Why?
History, 16th Century
1
2017
14
0.030
 Why?
History, 15th Century
1
2017
11
0.030
 Why?
United Arab Emirates
1
2017
7
0.030
 Why?
History, Ancient
1
2017
52
0.030
 Why?
History, Medieval
1
2017
44
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2025
810
0.030
 Why?
Recovery of Function
1
2021
641
0.030
 Why?
Drug Therapy, Combination
2
2012
1040
0.030
 Why?
Critical Care Outcomes
1
2016
12
0.030
 Why?
History, 21st Century
1
2017
183
0.030
 Why?
Cross-Sectional Studies
2
2021
5044
0.030
 Why?
Trauma Severity Indices
1
2016
104
0.030
 Why?
Probability
1
2017
305
0.030
 Why?
Lymphocyte Activation
1
2000
1109
0.030
 Why?
Refugees
1
2017
66
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2018
432
0.030
 Why?
Anxiety
1
2022
961
0.030
 Why?
Uteroglobin
1
2014
23
0.030
 Why?
Chemokine CXCL2
1
2014
43
0.030
 Why?
Cost-Benefit Analysis
1
2017
569
0.030
 Why?
Pilot Projects
1
2019
1583
0.030
 Why?
Arachidonate 5-Lipoxygenase
1
2014
42
0.030
 Why?
Rosuvastatin Calcium
1
2014
20
0.030
 Why?
Nitrites
1
2014
83
0.030
 Why?
MAP Kinase Kinase 4
1
2014
28
0.030
 Why?
Risk
1
2017
851
0.030
 Why?
Socioeconomic Factors
1
2018
1208
0.030
 Why?
Creatine Kinase
1
2014
73
0.030
 Why?
Epoxy Compounds
1
2014
32
0.030
 Why?
Nitrates
1
2014
88
0.030
 Why?
Quality Indicators, Health Care
1
2017
298
0.030
 Why?
Chondroitin Sulfates
1
2014
35
0.030
 Why?
Toll-Like Receptor 2
1
2014
113
0.030
 Why?
Kidney Function Tests
1
2014
152
0.030
 Why?
Manikins
1
2013
24
0.030
 Why?
Leukocyte Count
1
2014
326
0.030
 Why?
Liver Failure
1
2014
91
0.030
 Why?
Bronchial Spasm
1
2013
6
0.030
 Why?
Cryptogenic Organizing Pneumonia
1
2013
19
0.030
 Why?
Quality Improvement
1
2021
1095
0.030
 Why?
Contraindications
1
2013
90
0.030
 Why?
Chromatography, Liquid
1
2015
423
0.030
 Why?
Mass Spectrometry
1
2016
713
0.030
 Why?
Depression
1
2022
1306
0.030
 Why?
Anesthesiology
1
2013
45
0.030
 Why?
Glucuronidase
1
2012
44
0.020
 Why?
Protein C Deficiency
1
2012
8
0.020
 Why?
Connective Tissue Diseases
1
2013
82
0.020
 Why?
Cells, Cultured
1
2000
4075
0.020
 Why?
Knowledge Bases
1
2012
23
0.020
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2012
86
0.020
 Why?
Intestinal Perforation
1
2012
45
0.020
 Why?
Toll-Like Receptor 4
1
2014
263
0.020
 Why?
Triage
1
2014
206
0.020
 Why?
Renal Insufficiency
1
2014
149
0.020
 Why?
Quality of Health Care
1
2017
602
0.020
 Why?
Tandem Mass Spectrometry
1
2015
522
0.020
 Why?
Disease Management
1
2016
588
0.020
 Why?
Quality Assurance, Health Care
1
2014
317
0.020
 Why?
Endothelium
1
2012
121
0.020
 Why?
Water-Electrolyte Balance
1
2011
34
0.020
 Why?
Adoptive Transfer
1
2012
218
0.020
 Why?
Epistasis, Genetic
1
2012
70
0.020
 Why?
General Surgery
1
2013
152
0.020
 Why?
Cross-Over Studies
1
2013
520
0.020
 Why?
Cell Survival
1
2014
1074
0.020
 Why?
Microbial Viability
1
2011
83
0.020
 Why?
Superoxides
1
2011
201
0.020
 Why?
Internal Medicine
1
2013
241
0.020
 Why?
Enzyme Activation
1
2012
812
0.020
 Why?
Interleukin-8
1
2011
262
0.020
 Why?
Viruses
1
2011
100
0.020
 Why?
Longitudinal Studies
1
2017
2716
0.020
 Why?
Cell Separation
1
2011
316
0.020
 Why?
Single-Payer System
1
2009
2
0.020
 Why?
Arthroplasty, Replacement, Knee
1
2014
305
0.020
 Why?
Species Specificity
1
2011
574
0.020
 Why?
Disease-Free Survival
1
2011
644
0.020
 Why?
Administration, Inhalation
1
2011
666
0.020
 Why?
Cell Death
1
2011
354
0.020
 Why?
Survivors
1
2013
457
0.020
 Why?
Nitric Oxide
1
2014
895
0.020
 Why?
Information Dissemination
1
2011
204
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2011
832
0.020
 Why?
Advisory Committees
1
2010
216
0.020
 Why?
Case-Control Studies
1
2016
3372
0.020
 Why?
Self Report
1
2013
795
0.020
 Why?
Drug Resistance, Bacterial
1
2009
175
0.020
 Why?
Cell Line
1
2014
2775
0.020
 Why?
Total Quality Management
1
2008
60
0.020
 Why?
Ventilator Weaning
1
2008
36
0.020
 Why?
Precision Medicine
1
2012
386
0.020
 Why?
Microbial Sensitivity Tests
1
2009
347
0.020
 Why?
Placebos
1
2008
201
0.020
 Why?
Neutrophil Infiltration
1
2008
105
0.020
 Why?
Capillary Permeability
1
2008
140
0.020
 Why?
United States Food and Drug Administration
1
2008
204
0.020
 Why?
Health Plan Implementation
1
2008
137
0.020
 Why?
Interdisciplinary Communication
1
2008
184
0.020
 Why?
Drug Industry
1
2008
106
0.020
 Why?
Chemokines
1
2008
226
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2012
1201
0.020
 Why?
Acid-Base Equilibrium
1
2007
27
0.020
 Why?
Dose-Response Relationship, Drug
1
2011
2008
0.020
 Why?
Cost Control
1
2006
39
0.020
 Why?
Umbilical Veins
1
2006
61
0.020
 Why?
Medical Audit
1
2007
74
0.020
 Why?
CD8 Antigens
1
2006
75
0.020
 Why?
Ketones
1
2007
47
0.020
 Why?
Microcirculation
1
2007
145
0.020
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2006
107
0.020
 Why?
CD4 Antigens
1
2006
137
0.020
 Why?
Bacillus subtilis
1
2006
65
0.020
 Why?
Information Management
1
2006
15
0.020
 Why?
Cell Count
1
2006
311
0.020
 Why?
Fluorescent Antibody Technique
1
2006
375
0.020
 Why?
Genome-Wide Association Study
1
2012
1326
0.010
 Why?
User-Computer Interface
1
2006
147
0.010
 Why?
Interleukin-10
1
2006
300
0.010
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
252
0.010
 Why?
Polymorphism, Single Nucleotide
1
2012
2059
0.010
 Why?
Inflammation Mediators
1
2006
504
0.010
 Why?
Asthma
1
2017
2219
0.010
 Why?
Hypoglycemia
1
2007
427
0.010
 Why?
Endothelium, Vascular
1
2007
901
0.010
 Why?
Cardiotonic Agents
1
2001
126
0.010
 Why?
Hypothermia, Induced
1
2001
76
0.010
 Why?
RNA, Messenger
1
2006
2699
0.010
 Why?
Mass Screening
1
2006
1148
0.010
 Why?
Dopamine
1
2001
285
0.010
 Why?
Hypoglycemic Agents
1
2007
1220
0.010
 Why?
Anti-Inflammatory Agents
1
2001
480
0.010
 Why?
Insulin
1
2007
2325
0.010
 Why?
Douglas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (598) concept(s)
_
Co-Authors Expand Description
See all (77) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)